Terug
Dagbereik
€ 26,64
€ 27,19
52-Weeksbereik
€ 20,92
€ 27,94
Volume
29.576.037
50D / 200D Gem.
€ 26,63
/
€ 25,30
Vorige Slotkoers
€ 26,97
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 19,6 | 0,4 |
| P/B | 1,8 | 2,9 |
| ROE % | 8,9 | 3,7 |
| Net Margin % | 12,4 | 3,9 |
| Rev Growth 5Y % | -6,3 | 10,0 |
| D/E | 0,8 | 0,2 |
Koersdoel Analisten
Hold
€ 27,50
+2.7%
Low: € 24,00
High: € 35,00
Forward K/W
9,1
Forward WPA
€ 2,96
WPA Groei (sch.)
+0,0%
Omzet Sch.
61 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 2,23
€ 2,15 – € 2,31
|
52 B | 6 |
| FY2029 |
€ 2,19
€ 2,11 – € 2,27
|
52 B | 6 |
| FY2028 |
€ 2,45
€ 1,61 – € 2,91
|
55 B | 8 |
Belangrijkste Punten
Revenue declined -6,33% annually over 5 years
Generating 9,08B in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4,68%
Cash machine — converts 116,81% of earnings into free cash flow
Capital efficient — spends only 4,20% of revenue on capex
Groei
Revenue Growth (5Y)
-6,33%
Revenue (1Y)-1,65%
Earnings (1Y)-3,12%
FCF Growth (3Y)37,61%
Kwaliteit
Return on Equity
8,90%
ROIC7,52%
Net Margin12,42%
Op. Margin24,67%
Veiligheid
Debt / Equity
0,78
Current Ratio1,16
Interest Coverage5,78
Waardering
P/E Ratio
19,60
P/B Ratio1,76
EV/EBITDA14,16
Dividend Yield0,07%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1,65% | Revenue Growth (3Y) | 2,51% |
| Earnings Growth (1Y) | -3,12% | Earnings Growth (3Y) | 90,86% |
| Revenue Growth (5Y) | -6,33% | Earnings Growth (5Y) | -23,04% |
| Profitability | |||
| Revenue (TTM) | 62,58B | Net Income (TTM) | 7,77B |
| ROE | 8,90% | ROA | 3,73% |
| Gross Margin | 70,33% | Operating Margin | 24,67% |
| Net Margin | 12,42% | Free Cash Flow (TTM) | 9,08B |
| ROIC | 7,52% | FCF Growth (3Y) | 37,61% |
| Safety | |||
| Debt / Equity | 0,78 | Current Ratio | 1,16 |
| Interest Coverage | 5,78 | Dividend Yield | 0,07% |
| Valuation | |||
| P/E Ratio | 19,60 | P/B Ratio | 1,76 |
| P/S Ratio | 2,43 | PEG Ratio | -4,31 |
| EV/EBITDA | 14,16 | Dividend Yield | 0,07% |
| Market Cap | 152,28B | Enterprise Value | 218,55B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 62,58B | 63,63B | 59,55B | 100,33B | 81,29B |
| Net Income | 7,77B | 8,02B | 2,13B | 31,37B | 22,15B |
| EPS (Diluted) | 1,36 | 1,41 | 0,37 | 5,47 | 3,88 |
| Gross Profit | 44,01B | 41,85B | 30,34B | 62,09B | 46,88B |
| Operating Income | 15,44B | 16,48B | 5,29B | 37,55B | 20,79B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 208,16B | 213,40B | 226,50B | 197,21B | 181,48B |
| Total Liabilities | 121,39B | 124,90B | 137,21B | 101,29B | 104,01B |
| Shareholders' Equity | 86,48B | 88,20B | 89,01B | 95,66B | 77,20B |
| Total Debt | 67,42B | 66,99B | 70,85B | 34,86B | 37,00B |
| Cash & Equivalents | 1,14B | 1,04B | 2,85B | 416,00M | 1,94B |
| Current Assets | 42,90B | 50,36B | 43,33B | 51,26B | 59,69B |
| Current Liabilities | 36,98B | 43,00B | 47,79B | 42,14B | 42,67B |